Smartcella Holding Ab Raises Sek 328 Million To Advance And Accelerate Development Of The Company'S Technologies

SmartCella Holding AB, an innovative biotechnology and medtech company, today announces the raising of SEK 328 million to further advance and accelerate the development of core technologies in the company's three business units, Procella Therapeutics, Smartwise and SvedMed Solutions.